Serum Preptin and Amylin Levels in Polycystic Ovary Syndrome Patients

Recep Tayyip Erdogan University Training and Research Hospital80 enrolled

Overview

Preptin and amylin are pancreatic hormones which participate in glucose homeostasis. This study aims to evaluate how serum preptin and amylin levels are altered in polycystic ovary syndrome (PCOS) patients and healthy women based on BMI groups .

Materials and Methods: This is a cross-sectional review of 40 PCOS patients and 40 healthy women who were matched with respect to BMI (\<25 kg/m2 and ≥25 kg/m2).

Study Type

OBSERVATIONAL

Enrollment

Conditions

Polycystic Ovary Syndrome

Interventions

preptin and amylin levelDIAGNOSTIC_TEST

we will take both of group blood samples to compare them serum preptin and amylin

Eligibility

Sex: FEMALEMin age: 17 YearsMax age: 35 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: the patients with PCOS Exclusion Criteria: Cushing's syndrome 21-hydroxylase deficiency Congenital adrenal hyperplasia Thyroid dysfunction Hyperprolactinemia Diabetes Chronic cardiovascular Hepatic, renal, and hematologic diseases Malignancies Using oral contraceptives, anti-androgens, glucocorticoids, anti-hypertensives, anti-diabetics, calcium supplements and anti-obesity drugs and those who smoke or consume alcohol \-

Locations (1)

Recep Tayyip Erdogan University

Rize, Turkey (Türkiye)

Outcomes

Primary Outcomes

Serum Preptin and Amylin Levels with Respect to Body Mass Index in Polycystic Ovary Syndrome Patients

Serum Preptin and Amylin Levels will compare between groups

Time frame: six months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.